Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04202913 · ClinicalTrials.gov registry record · NA

Building Resilience for Healthy Kids

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
867
Enrollment target

NCT04202913: Completed NA study, sponsored by University of Colorado, Denver.

NCT04202913 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 867 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04202913, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
867 participants
Enrollment target

Study Summary

School based, mental-health intervention focused on improving self-efficacy and coping skills in children aged 9-13 years. The overall premise of our intervention is that by teaching children these skills they will in-turn become more resilient when faced with life-stressors and/or adverse events.

Primary Outcome

Assessment of a child's resiliency. Scores range from 17 (low resiliency) to 85 (high resiliency)

Interventions

  • BEHAVIORAL Coaching

Trial Details

FieldValue
Enrollment Target 867 participants
Start Date 2020-01-12
Est. Completion 2021-05-31
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT04202913 record still lists

NCT04202913 is an interventional study that assigns participants to a tested intervention. The registered 867 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).

The record links to 0 conditions, and to 1 intervention - of which Coaching is the first listed.

NCT04202913 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04202913 about?

NCT04202913 is a clinical study titled "Building Resilience for Healthy Kids". School based, mental-health intervention focused on improving self-efficacy and coping skills in children aged 9-13 years. The overall premise of our intervention is that by teaching children these skills they will in-turn become more resilient when faced with life-stressors and/or adverse events.

What is the current status of trial NCT04202913?

This trial is currently completed. It is a NA study. The enrollment target is 867 participants. The study started on 2020-01-12. Estimated completion is 2021-05-31.

What interventions are being tested in trial NCT04202913?

The interventions under investigation include: Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT04202913?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04202913's enrollment target sits among peer trials

867 130th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04933552 · 867 participants

    Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

  • NCT06077760 · 868 participants · Phase 3

    A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

  • NCT06822790 · 869 participants · Phase 3

    Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

  • NCT05369052 · 865 participants · Phase 3

    Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04202913, the US trial registry maintained by the National Library of Medicine. NCT04202913 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.